Statistics for Cell MedX (id:12259 CMXC)

Valuation metrics

Market cap

144.16M

Enterprise value

128.71M

Trailing P/E (ttm)

-35.14

Forward P/E

PEG ratio

Price/Sales (ttm)

Price/Book (mrq)

-10.17

Enterprise Value/Revenue

Enterprise Value/EBITDA

-282.33

Overview

Shares outstanding

297.24M

Float

63.77M

Shares short

% Held by insiders

0.79%

% Held by institutions

0.00%

Average volume (10 days)

522.00

Average volume (90 days)

Price summary

52-Week low

0.00

52-Week high

0.50

52-Week change

64.63%

Beta

32.65

50-Day moving average

0.39

200-Day moving average

0.41

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 05th, 2024

Financials

Fiscal year

Fiscal year ends

May 31th, 2024

Most recent quarter (mrq)

August 31th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-421.58%

Return on equity

17.24%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-132,452.00

Diluted EPS (ttm)

0.00

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

20.55K

Total cash per share (mrq)

0.00

Total debt (mrq)

321.29K

Total Debt/Equity (mrq)

-0.35

Current ratio (mrq)

2.40%

Book value per share (mrq)

0.00

Cash flow

Cash flow statement

-128,458.00

Levered free cash flow (LFCF)

-1,111,275.00